25 results
8-K
EX-10.1
AFIB
Acutus Medical Inc
9 Nov 23
Entry into a Material Definitive Agreement
6:41pm
be expected to last for more than three months; (ii) a recall which could reasonably be expected to result in aggregate liability to the Borrower
8-K
EX-10.1
AFIB
Acutus Medical Inc
1 Jul 22
Entry into a Material Definitive Agreement
6:47am
Product, which discontinuance, withdrawal or delay could reasonably be expected to last for more than three months; (ii) a recall which could
8-K
EX-2.1
AFIB
Acutus Medical Inc
27 Apr 22
Acutus Medical Announces Agreements to Fund Strategic Growth Priorities
6:30am
liability to the Seller or any voluntary or involuntary recall of any Seller Products, or similar written correspondence or written notice from the FDA … ) credits or allowances given or made for rejection, recall, return or wastage replacement, or for rebates or retroactive price reductions;
(c) price
8-K
EX-99.2
ff2xob77
12 Nov 21
Acutus Medical Reports Third Quarter 2021 Financial Results
5:16pm
424B4
8b5n 38dacevb8w
15 Jul 21
Prospectus supplement with pricing info
4:50pm
DRS
ljajkdmk
27 May 21
Draft registration statement
12:00am
10-K
g9ctn133st90ym3
19 Mar 21
Annual report
12:00am
424B4
m2migzlhyekb2rv ri
7 Aug 20
Prospectus supplement with pricing info
12:00am
S-1
EX-2.1
p59m m0lwvxqt
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.1
xvydy6o
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.4
n352qn39xga
15 Jul 20
IPO registration
4:53pm
S-1
9tl04o coxk
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.3
i6cdg
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.5
52u2xk
15 Jul 20
IPO registration
4:53pm
DRS/A
EX-10.4
891laq
29 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
3c059ifyrad 8qw9
29 Jun 20
Draft registration statement (amended)
12:00am